| Patents for C07D 333 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom (32,883) |
|---|
| 04/19/2006 | CN1760197A Pentafluorosulfanyl-substituted thienothiophene monomers and conducting polymers |
| 04/19/2006 | CN1252055C Biphenyl carboxamides compounds |
| 04/19/2006 | CN1252042C Oximate light initiator |
| 04/18/2006 | US7030242 Selective inhibition of aggrecanase in osteoarthritis treatment |
| 04/18/2006 | US7030153 Including methylsulfonyl attachment, treating arthritis, with analgesic activity without erosion of the stomach, side effect reduction |
| 04/18/2006 | US7029606 Hyperpolarizable organic chromophores |
| 04/18/2006 | CA2360943C N2-phenylamidine derivatives |
| 04/18/2006 | CA2207443C Tricyclic compounds |
| 04/18/2006 | CA2155666C Novel derivatives of 3-hydroxy anthranilic acid, methods and intermediates for their preparation, novel pharmaceutical compositions and the use thereof |
| 04/13/2006 | WO2006038606A1 Biaryl derivative |
| 04/13/2006 | WO2006038459A1 Organic thin-film transistor material, organic thin-film transistor, field effect transistor and switching device |
| 04/13/2006 | WO2006037982A2 Modulators of crth2 receptor activity for the treatment of prostaglandin d2 mediated diseases |
| 04/13/2006 | WO2006037761A1 New histone deacetylases inhibitors |
| 04/13/2006 | WO2005087752A3 Substituted hydroxyethylamine aspartyl protease inhibitors |
| 04/13/2006 | WO2005007621A3 Ubiquitin ligase inhibitors |
| 04/13/2006 | US20060079693 Method and intermediate for preparing a prostaglandin F-type compound |
| 04/13/2006 | US20060079506 Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors |
| 04/13/2006 | US20060079462 Organoselenium compounds for cancer chemoprevention |
| 04/12/2006 | EP1645557A1 Novel substance having alpha-glucosidase inhibiting activity and food containing the same |
| 04/12/2006 | EP1645552A1 Double-spiro organic compounds and electroluminescent devices |
| 04/12/2006 | EP1644350A1 Sulfamate benzothiophene derivatives as steroid sulfatase inhibitors |
| 04/12/2006 | EP1644322A1 Aspartyl protease inhibitors |
| 04/12/2006 | EP1644321A2 New benzamides as ppaty modulators |
| 04/12/2006 | EP1644320A1 Indane derivates as muscarinic receptor agonists |
| 04/12/2006 | EP1572677B1 Preparation of heterocyclic ketones |
| 04/12/2006 | EP1495015B1 3-aminophenol derivatives and dyes that contain these compounds while serving to dye keratin fibers |
| 04/12/2006 | EP1311499B1 Bicyclic compounds as h3 receptor ligands |
| 04/12/2006 | CN1759119A Method for the decarboxylation of dicarboxylic acids |
| 04/12/2006 | CN1758915A 10,10-dialkyl prostanoic acid derivatives as agents for lowering intraocular pressure |
| 04/12/2006 | CN1757645A Material contg. thiophene spirane structure, its synthesis and application |
| 04/12/2006 | CN1250735C Method for production of non-proteinogen L-amino acid by fermentation |
| 04/12/2006 | CN1250538C Conductive compound, electrode and sensor contain said conductive compound and method for detecting target molecule by using sad sensor |
| 04/11/2006 | US7026498 Coordination catalyst containing ligand |
| 04/11/2006 | US7026349 Sulfonamides |
| 04/11/2006 | US7026346 Anticancer agents |
| 04/11/2006 | US7026339 Inhibitors of HCV NS5B polymerase |
| 04/11/2006 | US7026094 oxime sulfonates, e.g., 2-[Cyano-(5-n-propanesulfonyloxyimino-5H-thiophen-2-ylidene)-methyl]-benzoic acid methyl ester with high stability and good solubility in the field of chemically amplified photoresists. |
| 04/11/2006 | CA2181570C Metalloproteinase inhibitors |
| 04/11/2006 | CA2178992C Process for the preparation of .alpha.-methyl-2-thiopheneacetic acid derivatives |
| 04/06/2006 | WO2006035122A1 Strontium ranelate alpha crystalline form, method for the preparation thereof and pharmaceutical compositions containing said agent |
| 04/06/2006 | WO2005108590A3 Method for producing optically active alcohols from alkanones using a dehydrogenase of azoarcus |
| 04/06/2006 | US20060074250 Charge transfer compounds, semiconductors, hole injection materials in optical, electrooptical or electronic devices; low band gap |
| 04/06/2006 | US20060074247 Improving storage stability by reacting with hydrogen sulfate lithium- containing compound; aspartyl protease inhibitors |
| 04/05/2006 | EP1642897A1 Alpha-crystalline form of Strontium Ranelate, process of preparation therof and pharmaceutical compositions containing it |
| 04/05/2006 | EP1642896A1 Pentafluorosulfanyl-substituted thienothiophene monomers and conducting polymers |
| 04/05/2006 | EP1641774A1 Pentafluoroalkanesulfinyl naphthalenes and related estrogen receptor modulators |
| 04/05/2006 | EP1641773A1 Process for preparing raloxifene hydrochloride |
| 04/05/2006 | EP1641765A1 Aryl-heteroaromatic products, compositions containing same and use thereof |
| 04/05/2006 | EP1641740A1 Method for producing an optically active nitro compound |
| 04/05/2006 | EP1524975B1 Improved transdermal delivery system for the administration of rotigotine |
| 04/05/2006 | EP1438104B1 Co-cycloalkyl 17-heteroaryl prostaglandin e2 analogs as ep2-receptor agonists |
| 04/05/2006 | EP1086098B1 Thienyl substituted acylguanidines as inhibitors of bone resorption and vitronectin receptor antagonists |
| 04/05/2006 | CN1756762A Method of generating metal chelating affinity ligands |
| 04/05/2006 | CN1754878A Strontium ranelate alpha crystalline form, method for the preparation thereof and pharmaceutical compositions containing said agent |
| 04/05/2006 | CN1754877A Anthracene derivative and organic electroluminescence device using the derivative |
| 04/05/2006 | CN1249060C Heterofluorene derivative with strong two photon absorption character |
| 04/05/2006 | CN1249051C Muscarinic agonists |
| 04/05/2006 | CN1249048C Process for preparation of 5-hydroxybenz [b] thiofuran-3-carboxylic acid derivative |
| 04/05/2006 | CN1249043C New heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them |
| 04/04/2006 | US7022739 Substituted 1-aminobutan-3-ol compounds |
| 04/04/2006 | US7022736 Enzyme inhibitors |
| 04/04/2006 | US7022731 Cardiovascular disorders; thrombosis; anticoagulants |
| 04/04/2006 | US7022726 ω-cycloalkyl 17-heteroaryl prostaglandin E2 analogs as EP2-receptor agonists |
| 04/04/2006 | US7022707 such as S-4-[(2-propylamino)carbonyl]oxybenzyl piperazine-1-thiocarboxylate for treatment of obesity and/or diabetes |
| 04/04/2006 | CA2256492C Diarylalkyl cyclic diamine derivatives as chemokine receptor antagonists |
| 03/30/2006 | WO2006034333A2 Control of parasites in animals by the use of novel trifluoromethanesulfonanilide oxime ether derivatives |
| 03/30/2006 | WO2006032893A2 Trityl derivatives for enhancing mass spectrometry |
| 03/30/2006 | WO2006010544A3 1, 1a, 5, 5a-tetrahydro-3-thia-cyclopropa’a! pentalenes: tricyclic thiophene derivatives as s1p1/edg1 receptor agonists |
| 03/30/2006 | WO2005123089A3 Multicyclic sulfonamide compounds as inhibitors of histone deacetylase for the treatment of disease |
| 03/30/2006 | WO2005120515A3 Novel sulfonamides as inhibitors of histone deacetylase for the treatment of disease |
| 03/30/2006 | WO2005081960A3 Inhibitors of protein tyrosine phosphatase 1b |
| 03/30/2006 | US20060069282 Process for producing aromatic nitrile compound |
| 03/30/2006 | US20060069272 Process for preparing 2,5-disubstituted 3-alkylthiophenes |
| 03/30/2006 | US20060069271 Alpha crystalline form of strontium ranelate |
| 03/30/2006 | US20060069257 Use of specific bidentate ligands, e.g., 2-dicyclohexylphosphino-2'-dimethylamino-biphenyl, in transition metal-catalyzed carbon-heteroatom and carbon-carbon bond-forming reactions including amination and arylation and with aryl halide reactants and amine, boronic acid, borane or ketone reactants |
| 03/30/2006 | US20060069255 Novel aryl ureido benzoic acid derivatives and their use |
| 03/30/2006 | US20060069098 Bone disorders; reduce concentration of parathyroid hormone in blood |
| 03/30/2006 | US20060069037 Peptide-containing alpha-ketoamide cysteine and serine protease inhibitors |
| 03/30/2006 | DE102005043371A1 Thiophenderivat und organisches elektrolumineszierendes Element Thiophene derivative and organic electro-luminescent element |
| 03/30/2006 | DE102004047840A1 Neue substituierte Thiophencarbonsäureamide, deren Herstellung und deren Verwendung als Arzneimittel New substituted thiophenecarboxamides, their preparation and their use as medicaments |
| 03/29/2006 | EP1640373A1 Process for producing 3-acylaminobenzofuran-2-carboxylic acid derivative |
| 03/29/2006 | EP1638964A1 Novel compounds that modulate ppar-gamma type receptors, and use thereof in cosmetic or pharmaceutical compositions |
| 03/29/2006 | EP1638927A1 Therapeutic agents |
| 03/29/2006 | EP1638924A1 Pesticidally active ketone and oxime derivatives |
| 03/29/2006 | EP1200395B1 Urea derivatives as inhibitors of ccr-3 receptor |
| 03/29/2006 | CN1753884A Opioid receptor antagonists |
| 03/29/2006 | CN1753883A Improved jasmine aromachemicals |
| 03/29/2006 | CN1752084A Heterocycle containing fluorene kind derivative and its preparation method |
| 03/29/2006 | CN1248033C Supertwisted nematic liquid crystal displays, liquid crystal compositions and compounds |
| 03/29/2006 | CN1247594C Bicyclic heteroaromatic compounds |
| 03/29/2006 | CN1247544C Anthranilic acid amides with heteroarylsulfonyl side chain and use thereof as active substance for antiarythmia |
| 03/29/2006 | CN1247529C Process for preparing N-aroyl-L-glutaminic acid |
| 03/29/2006 | CN1247528C Novel tricyclic compounds, preparation method and pharmaceutical compositions containing same |
| 03/29/2006 | CN1247511C Tropolone derivative |
| 03/28/2006 | USRE39050 Treating post-menopausal osteoporosis with raloxifene, formerly keoxifene, or raloxifene hydrochloride; new usage |
| 03/28/2006 | US7019453 For use as optical modulators, optical switches, and optical directional couplers |
| 03/28/2006 | US7019033 For therapy of cancer and other proliferative diseases such as inflammation, psoriasis and restenosis, as well as stroke, heart failure, and immunodeficiency disorders |
| 03/28/2006 | US7019030 Immunotherapeutic agents |
| 03/28/2006 | US7019027 2-amino-3-aroyl-4,5 alkylthiophenes: agonist allosteric enhancers at human A1 adenosine receptors |
| 03/28/2006 | US7019025 such as N-(4-{[methyl-(2-propynyl)amino]methyl}phenyl)-2-thiophenecarboximidamine; for inhibiting nitrogen oxide synthases and/or monoamine oxidases |